$TER

JOHNSON MERCEDES sold $62K of TER

JOHNSON MERCEDES sold 167 shares of TERADYNE, INC (TER) at $369.74 on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · JOHNSON MERCEDES
Published Jun 3, 2026, 8:54 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 9:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TER
Neutral
medium confidence
Mentioned
$TER
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TERNeutralLow
01

Why it matters

The disclosure provides incremental information about insider activity, but the pre-arranged 10b5-1 structure typically limits interpretability as a new negative catalyst.

02

Market read

A routine 10b5-1 insider sale; not a fundamental event like earnings, guidance, or a deal.

03

What to watch

Traders may want to compare with prior Form 4 activity (frequency/size) to judge whether this is isolated or part of a pattern.

Relevance 4/10Novelty 3/10Timing: SEC Form 4 filed June 3 for a June 2 sale

Background

This is an SEC Form 4 insider transaction disclosure (director selling) for Teradyne.

Company-level read

Ticker impact

$TERNeutralMedium confidence
Context

Teradyne director Johnson Mercedes sold 167 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low near-term impact; any effect is likely muted unless follow-on selling accelerates.

Evidence & confidence

The filing specifies a pre-arranged 10b5-1 plan and a small sale size relative to typical daily liquidity, reducing immediate fundamental interpretation.

Market effects

Minimal; single-company insider transaction without broader sector catalyst.

None.

None.

Counterpoint

Because it’s a 10b5-1 plan, the sale may reflect scheduled diversification rather than bearish expectations.

Key entities

  • TERADYNE, INC

    Company whose director insider sale was reported on SEC Form 4.

  • JOHNSON MERCEDES

    Director who sold 167 shares on June 2 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FORMMedAI 8/10

FormFactor, Entegris, Penguin Solutions, Teradyne, and Marvell Technology Stocks Trade Up, What You Need To Know

Several semiconductor stocks rose after the August jobs report, which showed 162,000 nonfarm payroll jobs added, beating estimates. Despite initial expectations of a rate hike, traders rotated back into the chip sector. FormFactor (FORM) +5.3%, Entegris (ENTG) +5.6%, Penguin Solutions (PENG) +5.1%, Teradyne (TER) +4.8%, and Marvell Technology (MRVL) +6.2%. Marvell reported Q2 revenue of $2.74B, up 36.5% YoY, with strong Data Center demand. Management guided Q3 revenue at $3.15B, but revenue from

$TERMed

Teradyne Stock Plunges 15% in a Month: Should You Buy the Dip?

Teradyne (TER) shares fell 15.4% in a month, underperforming peers and sector. Challenges include customer concentration and muted demand, but AI-driven data center growth and strong Q3 guidance offset this. TER expects $1.20-$1.30B revenue and $1.85-$2.15 EPS for Q3 2026, up significantly YoY. The stock trades at a premium with a forward P/S of 9.35X.

$TERHigh

Why is Teradyne stock sliding today?

Teradyne (TER) stock fell 3.9% after Baird downgraded it to Neutral with a $420 price target, citing stretched valuation and concerns over AI and hyperscaler spending sustainability. The firm argues GPU testing catalyst is priced in and next growth drivers are too distant. TER's decline contrasts with broader market gains, highlighting company-specific pressures.

$METAMed

Stocks making the biggest moves midday: Meta, Amylyx, Baidu, Klarna, Coherent, Sandisk & more

Amylyx Pharmaceuticals shares rose 53% after its avexitide treatment met trial endpoints. Meta Platforms fell 3% amid a lawsuit. Carvana dropped 3% after director stock sales. UGI Corporation surged 12% on a $9B KKR bid report. AI-related stocks declined. Klarna fell 21% on weak guidance. Baidu dropped 12% on earnings miss. Home Depot rose slightly on earnings beat. Fabrinet fell 20% on margin concerns. Memory stocks declined. Duolingo rose 7% on an upgrade.